Lucid Diagnostics Inc. (LUCD) Form 10-Q — May 13, 2026
Lucid Diagnostics Inc. reported a net loss of $13.9 million and used $12.1 million in cash from operations during the three months ended March 31, 2026. The company's cash position decreased from $34.7 million at the end of 2025 to $27.9 million as of March 31, 2026. These factors raise substantial doubt about the company's ability to continue as a going concern within one year after the financial statements are issued.
Key figures
- Eps Beat
- 0
- Revenue
- 1256
- Total Debt
- 25200
- Debt Amount
- 21975
- Total Assets
- 34080
- Cash Position
- 27876
- Deal Value Usd
- 0
- Interest Rate
- 12
- Maturity Date
- November 22, 2029
- Gross Proceeds
- 16800
- Offering Price
- 1
- Shares Offered
- 18000000
- Shares Outstanding
- 203066783
- Working Capital
- 2000
- 2024 Convertible Notes Face Value
- 21975
- 2024 Convertible Notes Fair Value
- 25200
Price after filing
1 day: 0.0%7 days: -2.0%30 days: -4.1%
Close on the filing date to close N calendar days later (from $1.02). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.